ASAdi Shabi Shlifer

Adi Shabi Shlifer

*This is an algorithmically generated author record based on publicly available information.

Adi Shabi Shlifer has a total of 7 co-authors. Here are the top co-authors by number of shared publications:

  • Erez Lang

    Sagol Center for Hyperbaric Medicine and Research, Shamir, Medical Center, Be’er Ya’akov, Israel

    1 shared publication
  • Gil Suzin

    Sagol Center for Hyperbaric Medicine and Research, Shamir, Medical Center, Be’er Ya’akov, Israel

    1 shared publication
  • Karin Elman-Shina

    Sagol Center for Hyperbaric Medicine and Research, Shamir, Medical Center, Be’er Ya’akov, Israel

    1 shared publication
  • Keren Doenyas-Barak

    Sagol Center for Hyperbaric Medicine and Research, Shamir, Medical Center, Be’er Ya’akov, Israel

    1 shared publication
  • Ran Shorer

    Sagol Center for Hyperbaric Medicine and Research, Shamir, Medical Center, Be’er Ya’akov, Israel

    1 shared publication
  • Shachar Finci

    Sagol Center for Hyperbaric Medicine and Research, Shamir, Medical Center, Be’er Ya’akov, Israel

    1 shared publication

Latest Publications

  • Open Access

    Hyperbaric oxygen therapy improves post-concussion symptoms in adults with childhood traumatic brain injury: a retrospective cohort study

    by Adi Shabi Shlifer, Gil Suzin, Ran Shorer, Erez Lang, Shachar Finci, Karin Elman-Shina, Keren Doenyas-Barak, Shai Efrati

    Post-concussion syndrome (PCS) following childhood traumatic brain injury (TBI) can result in persistent cognitive impairments that extend into adulthood, yet it remains significantly underdiagnosed and undertreated. This study evaluated the effects of hyperbaric oxygen therapy (HBOT) on chronic neurocognitive symptoms in adults with PCS stemming from pediatric TBI. We conducted a retrospective analysis of patients treated with HBOT at the “Sagol Center for Hyperbaric Medicine and Research” between 2017 and 2024. Inclusion criteria included TBI before age 17, HBOT initiation after age 20, and the availability of computerized cognitive assessments before and after treatment. All participants received at least 40 sessions of HBOT, consisting of 90 min of 100% oxygen at 2 ATA with air breaks. Twenty-six adults (mean age 31.7 ± 8.6 years) who sustained TBI in childhood (mean age at injury 7.7 ± 5.8 years) met inclusion criteria. Following HBOT, statistically significant improvements were observed in all cognitive domains except for motor skills (global cognition, memory, executive function, attention and information processing speed; all adjusted p < 0.05; effect sizes r = 0.62–0.78, Wilcoxon signed-rank test). These improvements were independent of time since injury (mean 23.6 ± 9.3 years) and initial TBI severity. Notably, individuals with a history of mild TBI exhibited similar impairments and treatment response to those with more severe injuries. These findings suggest that HBOT may induce meaningful neurocognitive improvement even decades after pediatric TBI, supporting its potential role in long-term rehabilitation strategies for this underserved population.